Research Comparison
Adipotide vs Cagrilintide (AM833)
A side-by-side research comparison of Adipotide and Cagrilintide (AM833) drawn from DRPSHP' peptide database records.
Adipotide
Adipotide, also catalogued as prohibitin-TP01, is a designed two-part molecule rather than something found in nature. One half is a homing sequence, CKGGRAKDC, a cyclic nine-residue peptide closed by a disulfide bond, which was picked out of phage-display libraries because it accumulates in the vasculature of white fat. The other half is D-(KLAKLAK)2, a synthetic amphipathic chain built from D-amino acids that has been used as a pro-apoptotic payload in other conjugates. Experiments were carried out in obese mice and then in rhesus monkeys, where changes in kidney tubule function were noted. Human data are very scarce, and most publications trace back to the group that engineered it.
Cagrilintide (AM833)
Native human amylin is a poor research tool: the 37-residue hormone that pancreatic beta cells release alongside insulin aggregates readily and does not last long in circulation. Analogues are engineered to get round both problems, and Cagrilintide is one of them — a synthetic amylin analogue carrying a fatty-acid side chain that binds albumin in blood, which lengthened its half-life in pharmacokinetic studies. It is described as acting at amylin receptors and at the calcitonin receptor. Animal work was followed by human clinical trials in metabolic research, both of the compound alone and alongside a GLP-1 receptor agonist. Set against the literature on amylin itself, the published pharmacology of this analogue is recent and narrow.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.